Vital Sign Monitoring System for User Experience
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new wireless system that continuously monitors vital signs, such as heart rate and oxygen levels, in hospital patients. The researchers aim to evaluate how effectively the system alerts nurses to changes and assess the satisfaction of both patients and nurses with its use. Patients admitted to the hospital for surgery or certain medical conditions who experience changes in vital signs might be suitable candidates for this trial. Participants should expect a hospital stay of at least two days.
As an unphased study, this trial provides a unique opportunity to contribute to advancements in patient care technology.
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how a new wCVSM (wearable Continuous Vital Signs Monitoring) software might improve alert frequency, and ultimately, nurse and patient satisfaction across different healthcare systems and cultures. Unlike traditional monitoring methods that may rely heavily on manual checks or stationary equipment, this software allows for continuous, real-time tracking of vital signs through wearable technology. This could lead to quicker response times and more personalized patient care. By understanding its impact across diverse healthcare settings, researchers hope to enhance patient outcomes and streamline healthcare processes globally.
Who Is on the Research Team?
Christian S Meyhoff, MD, PhD
Principal Investigator
Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
Eske K Aasvang, MD, DMSci
Principal Investigator
Rigshospitalet, Copenhagen University, Copenhagen, Denmark
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Monitoring
Participants are monitored with a wireless, continuous vital sign monitoring system for 4 days postoperatively or after acute admission
Follow-up
Participants are monitored for safety and effectiveness after the monitoring period
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Christian S. Meyhoff
Lead Sponsor
Rigshospitalet, Denmark
Collaborator